Clinical Trial Update: An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for an implant to treat hearing loss following Neurofibromatosis type 2 tumor removal; the study is completed. Sponsor: FDA Office…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type 2

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Neurofibromatosis 2 | Phase 1 | Status: COMPLETED